Deferasirox Fe3+ Chelate: Precision Iron Chelation Workflows
2026-07-08
Deferasirox Fe3+ chelate empowers iron overload research with exceptional DMSO solubility, high assay reproducibility, and advanced mechanistic precision. This guide delivers actionable workflows, troubleshooting advice, and comparative insights to optimize beta-thalassemia and chronic anemia studies.
Workflow Guidance for HyperPFU™ High-Fidelity DNA Polymerase
2026-07-08
HyperPFU™ high-fidelity DNA polymerase is designed for accurate PCR amplification of long, complex, or GC-rich DNA templates, where standard enzymes often fail due to low fidelity or processivity. It is not suitable for protocols requiring 3'-A overhangs or sticky ends, and should be used in workflows needing blunt-ended, high-fidelity products.
Inhibition of uPAR-uPA Interaction: IPR-803 in Breast Cancer
2026-07-07
This study demonstrates that IPR-803, a small-molecule urokinase receptor inhibitor, directly disrupts the uPAR-uPA interaction, effectively reducing breast cancer cell invasion and metastasis in vitro and in vivo. The paper offers mechanistic and pharmacokinetic evidence supporting IPR-803 as a foundational compound for translational anti-metastatic research.
ApexPrep DNA Plasmid Miniprep Kit: Precision Plasmid Purific
2026-07-07
Unlock high-yield, molecular biology grade plasmid DNA extraction with the ApexPrep DNA Plasmid Miniprep Kit. Streamline AML gene regulation studies and next-gen cloning with reproducible purity, rapid protocols, and robust troubleshooting guidance.
SR-202: Advancing PPARγ Antagonism in Immune-Metabolic Resea
2026-07-06
Explore how SR-202, a selective PPARγ antagonist, enables translational researchers to dissect immune-metabolic pathways, bridge the gap between mechanistic insight and therapeutic innovation, and redefine experimental strategies in obesity, type 2 diabetes, and inflammatory disease research.
SN-38 Inhibits FUBP1–FUSE Binding: New Insights for Cancer R
2026-07-06
The reference study reveals a novel mechanism for 7-Ethyl-10-hydroxycamptothecin (SN-38), showing it inhibits the binding of the oncoprotein FUBP1 to its DNA target sequence FUSE in addition to its established role as a topoisomerase I inhibitor. This dual-action effect has significant implications for advanced colon and liver cancer research, especially where FUBP1 is overexpressed.
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Workflow and QC Gui
2026-07-05
The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive, specific detection of rabbit IgG in immunofluorescence, immunohistochemistry, and related assays. It is best suited for research workflows requiring robust signal amplification and low background, but is not intended for diagnostic or in vivo applications.
AP20187: Chemical Inducer of Dimerization in Conditional Gen
2026-07-04
AP20187 empowers researchers to program protein-protein interactions with unmatched temporal control, unlocking next-generation workflows for conditional gene therapy and metabolic research. Its high solubility, purity, and proven in vivo efficacy distinguish it as a tool of choice for regulated cell signaling experiments.
Dantrolene Sodium Salt: Modulating DNA Repair via Calcium Si
2026-07-03
This thought-leadership article explores how Dantrolene sodium salt, a potent ryanodine receptor antagonist, enables translational researchers to precisely manipulate intracellular calcium signaling and DNA repair pathway choice. By integrating mechanistic insight with strategic protocol guidance, it positions Dantrolene at the intersection of CRISPR genome editing, synthetic lethality, and advanced disease modeling. The article uniquely connects calcium modulation to DNA double-strand break repair, referencing recent repurposing screens and highlighting APExBIO’s high-purity Dantrolene as an indispensable asset for next-generation research.
Ionomycin Free Acid: Catalyzing Next-Gen FAK–TNBC Research
2026-07-03
Explore how Ionomycin free acid, a selective calcium ionophore from APExBIO, empowers translational researchers to dissect FAK signaling in triple negative breast cancer (TNBC). This thought-leadership article weaves mechanistic insight, protocol guidance, and strategic foresight, contextualized by new findings on lncRNA FAISL-driven FAK stabilization and metastasis.
Breast Cancer's Dependence on MCL-1: Insights from Canonical
2026-07-02
This study demonstrates that breast cancer cell survival is critically dependent on the canonical anti-apoptotic function of MCL-1. By combining genetic deletion and selective inhibition, the authors show that MCL-1's role in apoptosis regulation, rather than non-apoptotic activities, underpins tumor growth and stem cell features, highlighting therapeutic implications for targeting MCL-1 in breast cancer.
Dabigatran Etexilate: Direct Thrombin Inhibitor in Research
2026-07-02
Dabigatran etexilate redefines anticoagulant research by enabling precise, reproducible modulation of thrombin activity through robust oral prodrug delivery. This guide delivers actionable protocols and troubleshooting insights for experimentalists studying coagulation and stroke prevention in atrial fibrillation models.
Phosphatase Inhibitor Cocktail 3 (100X in DMSO): Practical G
2026-07-01
Phosphatase Inhibitor Cocktail 3 (100X in DMSO) is designed to preserve protein phosphorylation by inhibiting a wide spectrum of serine/threonine and alkaline phosphatases during protein extraction and sample preparation. It is recommended for workflows analyzing phosphoproteins, such as Western blotting and kinase assays, but should not be used where phosphatase inhibition could interfere with intended enzymatic activity or downstream analyses.
Imipenem: Semisynthetic Thienamycin Antibiotic for Antibacte
2026-07-01
Imipenem is a semisynthetic thienamycin antibiotic with broad-spectrum activity against gram-negative and gram-positive bacteria. It demonstrates stability against many beta-lactamases and modulates immune responses in vitro and in vivo. This article details its mechanism of action, experimental benchmarks, and integration into antibacterial research workflows.
Sodium Ascorbate in Glioblastoma Research: Protocols & Innov
2026-06-30
Sodium Ascorbate, a mineral salt of ascorbic acid, empowers advanced tumor research through robust ROS-mediated mechanisms and unique necrotic cell death. This guide details optimized workflows, troubleshooting strategies, and practical assay enhancements—anchored by recent breakthroughs in tumor-immune crosstalk and biomarker-driven model selection.
466 records 13/32 page Previous Next First page 上5页 1112131415 下5页 Last page